223 related articles for article (PubMed ID: 6763967)
1. Immune status of subsided cases of tuberculoid (TT) and borderline tuberculoid (BT) leprosy.
Mackay IG; Sengupta U; Ghei SK; Sinha S; Ramu G
Lepr India; 1982 Oct; 54(4):653-63. PubMed ID: 6763967
[TBL] [Abstract][Full Text] [Related]
2. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacterium leprae and five selected cultivable mycobacteria.
Mustafa AS; Talwar GP
Lepr India; 1978 Oct; 50(4):566-71. PubMed ID: 374875
[No Abstract] [Full Text] [Related]
3. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to antigens from cultivable saprophytic mycobacteria.
Sharma RC; Singh R
Lepr India; 1978 Oct; 50(4):572-8. PubMed ID: 374876
[No Abstract] [Full Text] [Related]
6. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
Godal T; Myrvang B; Samuel DR; Ross WF; Lofgren M
Acta Pathol Microbiol Scand Suppl; 1973; 236(0):45-53. PubMed ID: 4602874
[No Abstract] [Full Text] [Related]
7. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
8. Bacillaemia and Mycobacterium leprae cell wall antigen in paucibacillary leprosy.
Kaur I; Kaur S; Sharma VK; Agnihotri N; Vaishnavi C; Ganguly NK
Indian J Lepr; 1993; 65(3):283-8. PubMed ID: 8283063
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
10. Sequential histological study of lepromin reaction.
Desikan KV; Mukherjee A; Ramu G; Tiwari VD
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):473-80. PubMed ID: 6686971
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
Tadesse A; Taye E; Sandoval F; Shannon EJ
Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
[TBL] [Abstract][Full Text] [Related]
12. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
[TBL] [Abstract][Full Text] [Related]
15. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
[TBL] [Abstract][Full Text] [Related]
16. [Change in cell-mediated immunity to Mycobacterium leprae and Mycobacterium marinum in Hansen's disease patients].
Fliess EL; Ortiz MC; Corn J
Hansenol Int; 1983 Jun; 8(1):9-17. PubMed ID: 6432692
[TBL] [Abstract][Full Text] [Related]
17. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
18. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
Ramanathan VD; Thyagi P; Ramanathan U; Katoch K; Ramu G
Indian J Lepr; 1998; 70(2):153-60. PubMed ID: 9724850
[TBL] [Abstract][Full Text] [Related]
19. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
[TBL] [Abstract][Full Text] [Related]
20. Salivary immunoglobulins and antibody activities in leprosy.
Abe M; Yoshino Y; Minagawa F; Miyaji I; Sampoonachot P; Ozawa T; Sakamoto Y; Saito T; Saikawa K
Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):343-50. PubMed ID: 6541202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
